*National Institutes of Health, Bethesda, MD
†Toulouse Center of Research on Cancer-Oncopole, CHU Toulouse, CRCT Inserm U1037, Toulouse, France
‡European Institute of Oncology, IRCCS—Scientific Institute for Research, Hospitalization and Health Care, Milan, Italy
§Hospital Clinic of Barcelona, University of Barcelona, Barcelona
¶JimĂ©nez DĂaz Foundation University Hospital, Madrid, Spain
∥Department of Pathology, University of Pittsburgh, Pittsburgh, PA
#City of Hope Medical Center, Duarte
**Department of Pathology, Stanford University, Stanford, CA
††British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada
Conflicts of Interest and Source of Funding: Supported by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute. S.P. is supported by a grant (n. 21198) of the Italian Association for Cancer Research, Milan, Italy. The remaining authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Elaine S. Jaffe, MD, Center for Cancer Research, National Cancer Institute, Building 10, Room 3S235, Bethesda, MD 20892-1500 (e-mail: [email protected]).
